Faus Moliner, Autor en Faus Moliner

Back to Capsulas

A quick “flash” on seven key topics to keep top of mind as we kick off the new season and Q4 2026

Jordi Faus, Lluís Alcover, Joan Carles Bailach, Juan Martínez and Claudia Gonzalo

10 Sep 2026

Capsulas Nº 276

Summary of the presentations given by the Faus Moliner team at the 20th Pharmaceutical Law Course organised by the CEFI Foundation

Lluís Alcover, Joan Carles Bailach, Anna Gerbolés and Claudia Gonzalo participated as speakers. Jordi Faus delivered the closing lecture

Jordi Faus, Lluís Alcover, Joan Carles Bailach, Anna Gerboles and Claudia Gonzalo

6 Nov 2025

Capsulas Nº 267

Who sold my cheese?

Reflections on territorial exclusivity clauses following the CJEU ruling in Case C-581/23 (Beevers Kaas)

Jordi Faus, Claudia Gonzalo

23 Sep 2025

Capsulas Nº 265

Finally, the Spanish reference pricing system becomes more flexible

Law 7/2025, which establishes the National Public Health Agency, published in the Official State Gazette (BOE) on 29 July, amends Article 98 of the LGURMPS

Jordi Faus

29 Jul 2025

Capsulas Nº 264

Facing the challenge of regulating conflicts of interest at national and European levels

Summary of Jordi Faus' speech at the 24th SEDISA National Congress

Jordi Faus

2 Jul 2025

Capsulas Nº 262

Promotion of approved products in Spain prior to completion of price and reimbursement procedures: a paradigm shift?

The rules on minimum content of advertising materials should not be an obstacle to promote an approved product even if its price and reimbursement decision is pending

Jordi Faus, Anna Gerboles

27 Mar 2025

Capsulas Nº 259

What news may we expect in Spain’s pharmaceutical policy in the next few months?

Some notes on the intervention of the Secretary of State for Health in Congress on October 14

Jordi Faus, Joan Carles Bailach

17 Oct 2024

Capsulas Nº 256

The Supreme Court confirms that companies have locus standi to challenge the marketing authorisation granted to a competitor

Judgments of the Supreme Court, Nos. 827/2024 and 1241/2024, of 14 May and 10 July

Jordi Faus, Juan Martínez and Joan Carles Bailach

30 Sep 2024

Capsulas Nº 255

Access to medicinal products and constitutional rights

Three new judgements, two from the Supreme Court and one from the High Court of Justice of Galicia, provide new insights on this matter

Jordi Faus, Joan Carles Bailach

29 Apr 2024

Capsulas Nº 251

Price increases of medicinal products that are not reimbursed

The Judgment of the High Court of Justice of Madrid of 10 May 2023 limits the authority of the administration in this matter

Jordi Faus

28 Jun 2023

Back to Capsulas

A quick “flash” on seven key topics to keep top of mind as we kick off the new season and Q4 2026

Capsulas Nº 276

Summary of the presentations given by the Faus Moliner team at the 20th Pharmaceutical Law Course organised by the CEFI Foundation

Lluís Alcover, Joan Carles Bailach, Anna Gerbolés and Claudia Gonzalo participated as speakers. Jordi Faus delivered the closing lecture

Capsulas Nº 267

Who sold my cheese?

Reflections on territorial exclusivity clauses following the CJEU ruling in Case C-581/23 (Beevers Kaas)

Capsulas Nº 265

Finally, the Spanish reference pricing system becomes more flexible

Law 7/2025, which establishes the National Public Health Agency, published in the Official State Gazette (BOE) on 29 July, amends Article 98 of the LGURMPS

Capsulas Nº 264

Facing the challenge of regulating conflicts of interest at national and European levels

Summary of Jordi Faus' speech at the 24th SEDISA National Congress

Capsulas Nº 262

Promotion of approved products in Spain prior to completion of price and reimbursement procedures: a paradigm shift?

The rules on minimum content of advertising materials should not be an obstacle to promote an approved product even if its price and reimbursement decision is pending

Capsulas Nº 259

What news may we expect in Spain’s pharmaceutical policy in the next few months?

Some notes on the intervention of the Secretary of State for Health in Congress on October 14

Capsulas Nº 256

The Supreme Court confirms that companies have locus standi to challenge the marketing authorisation granted to a competitor

Judgments of the Supreme Court, Nos. 827/2024 and 1241/2024, of 14 May and 10 July

Capsulas Nº 255

Access to medicinal products and constitutional rights

Three new judgements, two from the Supreme Court and one from the High Court of Justice of Galicia, provide new insights on this matter

Capsulas Nº 251

Price increases of medicinal products that are not reimbursed

The Judgment of the High Court of Justice of Madrid of 10 May 2023 limits the authority of the administration in this matter

Capsulas Nº 239

Uso de cookies